Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi A infection in healthy adult volunteers (2023)

First Author: McCann N
Attributed to:  Development of a Live Attenuated Vaccine Against Salmonella Paratyphi (VASP) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2022-068966

Publication URI: http://dx.doi.org/10.1136/bmjopen-2022-068966

Type: Journal Article/Review

Parent Publication: BMJ Open

Issue: 5